Slow versus fast proteins in the stimulation of beta-cell response and the activation of the entero-insular axis in type 2 diabetes

Diabetes/Metabolism Research and Reviews

Volumn 23, Issue 5, 2007, Pages 378-385

  Tessari, Paolo ^a   Kiwanuka, Edward ^a   Cristini, Michela ^a   Zaramella, Michela ^a   Enslen, Marc ^b   Zurlo, Corinna ^a   Garcia Rodenas, Clara ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Amino acids; Fast proteins; GIP; GLP 1; Insulin secretion; Slow proteins

Indexed keywords

AMINO ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BEZAFIBRATE; C PEPTIDE; CASEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GASTRIC INHIBITORY POLYPEPTIDE; GLIBENCLAMIDE PLUS METFORMIN; GLICLAZIDE; GLIPIZIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; MILK PROTEIN; ORAL ANTIDIABETIC AGENT; PROINSULIN; REPAGLINIDE;

ADULT; AMINO ACID BLOOD LEVEL; AMINOACIDEMIA; ARTICLE; CALORIE; CELL ACTIVATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETIC DIET; DIET THERAPY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERTENSION; INGESTION; INSULIN RELEASE; LOW CALORY DIET; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN DIET; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; WHEY;

AMINO ACIDS; BODY MASS INDEX; CASEINS; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DIGESTION; FEMALE; HUMANS; INSULIN-SECRETING CELLS; INTESTINAL ABSORPTION; KINETICS; MALE; MIDDLE AGED; MILK PROTEINS;

EID: 34447636241     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.698     Document Type: Article

References (31)

1. De Fronzo RA, Bonadonna RC, Ferrannini E. (1992) Pathogenesis of NIDDM: a balanced overview. Diabetes Care 1992; 15: 318-368.
2. Groop LC, Widén E, Ferrannini E. (1993) Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non - insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Diabetologia 1993; 36: 1326-1331.
3. Floyd JC Jr, Fajans SS, Conn JW, et al. Secretion of insulin induced by amino acids and glucose in diabetes mellitus. J Clin Endocrinol Metab 1968; 28: 266-276.
4. Nuttall FQ, Gannon MC. Quantitative importance of dietary constituents other than glucose as insulin secretagogues in type 2 diabetes. Diabetes Care 1988; 11: 72-76.
5. Porte D Jr, Kahn SE. The key of islet dysfunction in type 2 diabetes mellitus. Clin Invest Med 1995; 18: 247-254.
6. Berger S, Vongaraya M. Insulin response to ingested protein in diabetes. Diabetes 1996; 15: 303-306.
7. Creutzfeldt W, Nauck M. Gut hormones and diabetes mellitus. Diabetes Metab Rev 1992; 8: 149-177.
8. Gannon MG, Nuttal FQ, Lane JT, Burnmeister LA. Metabolic response to cottage cheese or egg white protein, with or without glucose, in type II diabetic subjects. Metabolism 1992; 41: 1137-1145.
9. Boirie Y, Dangin M, Gachon P, et al. Slow and fast dietary proteins differently modulate postprandial protein accretion. Proc Natl Acad Sci U S A 1997; 94: 14930-14935.
10. Dangin M, Boirie Y, Garcia-Rodenas C, et al. The digestion rate of protein is an independent regulating factor of postprandial protein retention. Am J Physiol Endocrinol Metab 2001; 280: E340-E348.
11. Hall WL, Millward DJ, Long SJ, Morgan LM. Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite. Br J Nutr 2003; 89: 239-248.
12. Dangin M, Guillet C, Garcia-Rodenas C, et al. The rate of protein digestion affects protein gain differently during aging in humans. J Physiol 2003; 549: 635-644.
13. Hother-Nielsen O, Faber O, Schwarz Sorensen N, Beck-Nielsen H. Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables. Diabetes Care 1998; 11: 531-537.
14. Prando R, Odetti P, Melga P, et al. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Diabetes Metab 1996; 22: 185-191.
15. Irving SY, Simone SD, Hicks FW, Verger JT. Nutrition for the critically Ill child: enteral and parenteral support. AACN Clin Issues 2000; 11(4): 541-558.
16. Tessari P, Biolo G, Bruttomesso D, et al. Effects of metformin treatment on whole-body and splanchnic amino acid turnover in mild type 2 diabetes. J Clin Endocrinol Metab 1994; 79: 1553-1560.
17. Kuzuya H, Bliz PM, Howitz DL, et al. Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 1977; 26: 22-29.
18. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostatic model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
19. 15N]beta-lactoglobulin and casein in humans: the influence of the nature and quantity of the protein. Am J Clin Nutr 1996; 63: 546-552.
20. Gougeon R, Styhler K, Morais JA, et al. Effect of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes. Diabetes Care 2000; 23: 1-8.
21. Kraup T. Immunoreactive gastric inhibitory po1ypeptide. Endocr Rev 1988; 9: 122-134.
22. Holst JJ, Ørskov C. Incretin hormones: an update. Scand J Clin Lab Invest 2001; 61(Suppl. 234): 75-86.
23. Bell GI, Sanchez-Pescador R, Laybourn PJ, Najarian RC. Exon duplication and divergence in the human pre-proglucagon gene. Nature 1983; 304: 368-371.
24. Nauck M, Stockmann F, Ebert R, Creutzfeldt W. Reduced incretin effect in type 2 (non insulin-dependent) diabetes. Diabetologia 1986; 29: 46-52.
25. Meneilly GS, Demuth HU, McIntosh CCHS, Pederson PA. Effect of ageing and diabetes on glucose-dependent insulinotropic polypeptide and dipeptidyl peptidase IV responses to oral glucose. Diabet Med 2000; 17: 346-350.
26. Vaag AA, Holst JJ, Volund A, Beck-Nielsen HB. Gut incretin hormones in identical twins discordant for non-insulin dependent diabetes mellitus (T2DM) - evidence for decreased glucagon-like-peptide 1 secretion during oral glucose ingestion in T2DM twins. Eur J Endocrinol 1996; 135: 425-432.
27. Gunnarsson PT, Winzell MS, Deacon CF, et al. Glucose-induced incretin hormone release and inactivation are differently modulated by oral fat and protein in mice. Endocrinology 2006; 147(7): 3173-3180.
28. Kjems LL, Hoist JJ, Volund A, Madsbad S. The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects. Diabetes 2003; 52: 380-386.
29. Ranganath L, Morgan L. An osmotic stimulus-mediating glucagon-like peptide-1 (7-36 amide) (GLP-1) secretion in acarbose-induced sucrose malabsorption? Nutrition 2000; 16(1): 64-65.
30. Frid AH, Nilsson M, Holst JJ, Bjorck IM. Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. Am J Clin Nutr 2005; 82(1): 69-75.
31. Tomas E, Lin YS, Dagher Z, et al. Hyperglycemia and insulin resistance: possible mechanisms. Ann N Y Acad Sci 2002; 967: 43-51.